Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Diagnosis of drug-resistant TB and provision of second-line TB treatment in India: some ethical considerations.

Singh JA, Bhan A, Upshur R.

Indian J Med Ethics. 2013 Apr-Jun;10(2):110-4.

PMID:
23697491
2.

Diagnosing pulmonary tuberculosis with the Xpert MTB/RIF test.

Bodmer T, Ströhle A.

J Vis Exp. 2012 Apr 9;(62):e3547. doi: 10.3791/3547.

3.

The Potential Impact of Up-Front Drug Sensitivity Testing on India's Epidemic of Multi-Drug Resistant Tuberculosis.

Sachdeva KS, Raizada N, Gupta RS, Nair SA, Denkinger C, Paramasivan CN, Kulsange S, Thakur R, Dewan P, Boehme C, Arinaminpathy N.

PLoS One. 2015 Jul 1;10(7):e0131438. doi: 10.1371/journal.pone.0131438.

4.

Ethical aspects of the Revised National Tuberculosis Control Programme.

Nair SS.

Indian J Med Ethics. 2011 Apr-Jun;8(2):102-6.

PMID:
22106620
5.

Contribution of medical colleges to tuberculosis control in India under the Revised National Tuberculosis Control Programme (RNTCP): lessons learnt & challenges ahead.

Sharma SK, Mohan A, Chauhan LS, Narain JP, Kumar P, Behera D, Sachdeva KS, Kumar A; Task Force for Involvement of Medical Colleges in Revised National Tuberculosis Control Programme., Agarwal P, Awadh NT, Bansal A, Baruah S, Baruwa P, Balasangameshwara VH, Balasubramanian R, Bhardwaj AK, Bhargav S, Chadha S, Chaddha VK, Chhatwal M, Da Costa AL, Dash DP, Dep J, Dhingra S, Dhooria Harmeet S, Frieden TR, Garg A, Granich R, Gulati V, Gupta D, Gupta D, Gupta KB, Gupta KN, Jaikishan, Janmeja AK, Jawahar MS, Jethani SL, Jindal SK, John KR, Kalra OP, Kalra VP, Kannan AT, Kayshap S, Keshav Chander G, Khushwa SS, Kushwaha RS, Kumar V, Laskar B, Leela Itty Amma KR, Leuva AT, Maitra Malay K, Mesquita AM, Mathew T, Mundade Y, Munje R, Nagpal S, Nagaraja C, Nair S, Narayanan OR, Paramasivan CN, Parmar M, Prasad R, Phukan AC, Prasanna R, Purty A, Ramachandran R, Ramachandran R, Ravindran C, Reddy Raveendra HR, Sahu S, Santosha, Sarin R, Sarkar S, Sarma KC, Saxena P, Sehgal S, Sharath N, Sharma G, Sharma N, Shridhar PK, Shukla RS, Singh O, Singh NT, Singh V, Singla R, Sinha N, Sinha P, Sinha S, Solanki R, Sreenivas A, Srinath S, Subhakar K, Suri JC, Talukdar P, Tonsing J, Tripathy SP, Vaidyanathan P, Vashist RP, Venu K.

Indian J Med Res. 2013 Feb;137(2):283-94.

6.
7.

Feasibility of decentralised deployment of Xpert MTB/RIF test at lower level of health system in India.

Raizada N, Sachdeva KS, Sreenivas A, Vadera B, Gupta RS, Parmar M, Kulsange S, Babre A, Thakur R, Gray C, Ramachandran R, Alavadi U, Ghedia M, Vollepore B, Dewan P, Boehme C, Paramsivan CN.

PLoS One. 2014 Feb 26;9(2):e89301. doi: 10.1371/journal.pone.0089301.

8.

[Comparing performance of "TB-BIOCHIP", "Xpert MTB/RIF" and "genotype MTBDRplus" assays for fast identification of mutations in the Mycobacterium tuberculosis complex in sputum from TB patients].

Nosova EIu, Krasnova MA, Galkina KIu, Makarova MV, Litvinov VI, Moroz AM.

Mol Biol (Mosk). 2013 Mar-Apr;47(2):267-74. Russian.

PMID:
23808160
9.

New vision for Revised National Tuberculosis Control Programme (RNTCP): Universal access - "reaching the un-reached".

Sachdeva KS, Kumar A, Dewan P, Kumar A, Satyanarayana S.

Indian J Med Res. 2012 May;135(5):690-4. Review.

10.

Is one sputum specimen as good as two during follow-up cultures for monitoring multi drug resistant tuberculosis patients in India?

Nagaraja SB, Kumar AM, Sachdeva KS, Ramachandran R, Satyanarayana S, Bansal A, Parmar M, Chadha S, Nair S, Kumar A, Hinderaker SG, Edginton M, Dewan PK.

PLoS One. 2012;7(9):e45554. doi: 10.1371/journal.pone.0045554.

11.

Revised national TB control programme in India.

Chauhan LS, Tonsing J.

Tuberculosis (Edinb). 2005 Sep-Nov;85(5-6):271-6.

PMID:
16253562
12.

RNTCP 2007: looking ahead to future challenges.

Chauhan LS.

J Indian Med Assoc. 2007 Apr;105(4):192, 194, 196.

PMID:
17822187
13.

Xpert® MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how?

Trébucq A, Enarson DA, Chiang CY, Van Deun A, Harries AD, Boillot F, Detjen A, Fujiwara PI, Graham SM, Monedero I, Rusen ID, Rieder HL.

Int J Tuberc Lung Dis. 2011 Dec;15(12):1567-72. doi: 10.5588/ijtld.11.0392.

PMID:
22005110
14.

First- and second-line drug resistance patterns among previously treated tuberculosis patients in India.

Paramasivan CN, Rehman F, Wares F, Sundar Mohan N, Sundar S, Devi S, Narayanan PR.

Int J Tuberc Lung Dis. 2010 Feb;14(2):243-6.

PMID:
20074419
15.

Prevalence of initial drug resistance to M. tuberculosis in new sputum positive RNTCP patients.

Dhingra VK, Rajpal S, Bhalla P, Yadav A, Jain SK, Hanif M.

J Commun Dis. 2003 Jun;35(2):82-9.

PMID:
15562953
16.

Clinical response of newly diagnosed HIV seropositive & seronegative pulmonary tuberculosis patients with the RNTCP Short Course regimen in Pune, India.

Tripathy S, Anand A, Inamdar V, Manoj MM, Khillare KM, Datye AS, Iyer R, Kanoj DM, Thakar M, Kale V, Pereira M, Risbud AR.

Indian J Med Res. 2011 May;133:521-8.

17.

Certification of TB culture and drug susceptibility testing laboratories through the Revised National Tuberculosis Control Programme (RNTCP).

Sachdeva KS, Nagaraja SB, Kumar A, Kumar P, Ramachandran R.

J Indian Med Assoc. 2012 Jul;110(7):488-9.

PMID:
23520677
18.

Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: a meta-analysis.

Chang K, Lu W, Wang J, Zhang K, Jia S, Li F, Deng S, Chen M.

J Infect. 2012 Jun;64(6):580-8. doi: 10.1016/j.jinf.2012.02.012.

PMID:
22381459
20.

Characteristics and programme-defined treatment outcomes among childhood tuberculosis (TB) patients under the national TB programme in Delhi.

Satyanarayana S, Shivashankar R, Vashist RP, Chauhan LS, Chadha SS, Dewan PK, Wares F, Sahu S, Singh V, Wilson NC, Harries AD.

PLoS One. 2010 Oct 12;5(10):e13338. doi: 10.1371/journal.pone.0013338.

Supplemental Content

Support Center